Prof. Dr. MURAT KAZIM ERSANLI

Yayın Ağı

Makaleler 77

1. Response to the Letter entitled: “Subclinical Myocardial Dysfunction in Systemic Lupus Erythematosus: The Role of Layer-Specific Strain and Clinical Modifiers”

Gürsoy M., ERSANLI M. K., BARMAN H. A., DOĞAN Ö.

Echocardiography , cilt.43, sa.5, 2026 (SCI-Expanded, Scopus)

2. Letter: Remnant Cholesterol as a Predictor of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

DOĞAN Ö., BARMAN H. A., EBEOĞLU A. Ö., EBEOĞLU Ş. İ., Nayir A., Kaya M., et al.

ANGIOLOGY , 2026 (SCI-Expanded, Scopus)

3. The impact of diabetes duration and glycemic control on ejection fraction in heart failure patients

DOĞAN Ö., BARMAN H. A., Serin E., Ebeoglu A. O., Atici A., Turkmen R., et al.

Acta Diabetologica , cilt.62, sa.10, ss.1787-1795, 2025 (SCI-Expanded, Scopus)

4. Evaluation of potential links between phenotypic features and genetic variants in left ventricular outflow tract obstruction in hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging

Gueven B., Can T. S., DENİZ M. F., GEÇİT M. H., GEYLAN N. A., SİNAN Ü. Y., et al.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING , cilt.40, sa.11, ss.2417-2428, 2024 (SCI-Expanded, Scopus)

5. The Relationship between Coronary Flow Reserve and the TyG Index in Patients with Gestational Diabetes Mellitus

ÖZYILDIRIM S., BARMAN H. A., Dogan O., ERSANLI M. K., DOĞAN S. M.

Medicina (Lithuania) , cilt.59, sa.10, 2023 (SCI-Expanded, Scopus)

6. Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice Reply

DOĞAN Ö., BARMAN H. A., GÖKÇE M. E., DÖNMEZ A., ERSANLI M. K.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.8, ss.599, 2021 (SCI-Expanded, Scopus, TRDizin)

7. A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor

DOĞAN Ö., BARMAN H. A., GÖKÇE M. E., DÖNMEZ A., ERSANLI M. K.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.5, ss.352-354, 2021 (SCI-Expanded, Scopus, TRDizin)

8. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Bittner V. A., Szarek M., Aylward P. E., Bhatt D. L., Diaz R., Edelberg J. M., et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.75, sa.2, ss.133-144, 2020 (SCI-Expanded, Scopus)

9. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

Verheugt F. W. A., Ambrosio G., Atar D., Bassand J., Camm A. J., Costabel J. P., et al.

AMERICAN JOURNAL OF MEDICINE , cilt.132, sa.12, ss.1431-1447, 2019 (SCI-Expanded, Scopus)

10. The association of neutrophil to lymphocyte ratio and TIMI frame count in primary percutaneous coronary intervention

Kocas C., Abaci O., ARSLAN Ş., Bostan C., Coskun U., Akturk F., et al.

Minerva cardioangiologica , cilt.67, sa.6, ss.471-476, 2019 (SCI-Expanded, Scopus)

11. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Roe M. T., Li Q. H., Bhatt D. L., Bittner V. A., Diaz R., Goodman S. G., et al.

CIRCULATION , cilt.140, sa.19, ss.1578-1589, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Szarek M., Steg P. G., DiCenso D., Bhatt D. L., Bittner V. A., Budaj A., et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES , cilt.12, sa.11, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The impact of the new World Symposium on Pulmonary Hypertension definition of pulmonary hypertension on the prevalence of pre-capillary pulmonary hypertension

SİNAN Ü. Y., Cetinarslan O., Ozkan A. A., ERSANLI M. K., Kucukoglu M. S.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.47, sa.7, ss.594-598, 2019 (ESCI, Scopus, TRDizin)

14. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

White H. D., Steg P. G., Szarek M., Bhatt D. L., Bittner V. A., Diaz R., et al.

EUROPEAN HEART JOURNAL , cilt.40, sa.33, ss.2801-2809, 2019 (SCI-Expanded, Scopus)

15. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

Jukema J. W., Szarek M., Zijlstra L. E., de Silva H. A., Bhatt D. L., Bittner V. A., et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.74, sa.9, ss.1167-1176, 2019 (SCI-Expanded, Scopus)

16. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Goodman S. G., Aylward P. E., Szarek M., Chumburidze V., Bhatt D. L., Bittner V. A., et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.74, sa.9, ss.1177-1186, 2019 (SCI-Expanded, Scopus)

17. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray K. K., Colhoun H. M., Szarek M., Baccara-Dinet M., Bhatt D. L., Bittner V. A., et al.

The Lancet Diabetes and Endocrinology , cilt.7, sa.8, ss.618-628, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Steg P. G., Szarek M., Bhatt D. L., Bittner V. A., Bregeault M., Dalby A. J., et al.

CIRCULATION , cilt.140, sa.2, ss.103-112, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

Cools F., Wollaert B., Veryoort G., Verstraete S., Voet J., Hermans K., et al.

ACTA CARDIOLOGICA , cilt.74, sa.4, ss.309-318, 2019 (SCI-Expanded, Scopus)

20. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

Haas S., Camm A. J., Bassand J., Angchaisuksiri P., Cools F., Corbalan R., et al.

AMERICAN HEART JOURNAL , cilt.213, ss.35-46, 2019 (SCI-Expanded, Scopus)

21. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry

Corbalan R., Bassand J., Illingworth L., Ambrosio G., Camm A. J., Fitzmaurice D. A., et al.

JAMA CARDIOLOGY , cilt.4, sa.6, ss.526-548, 2019 (SCI-Expanded, Scopus)

22. Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry

Sayin B. Y., Okutucu S., YILMAZ M. B., Ozdemir K., AYDINLAR A., Sahin D. Y., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.21, sa.5, ss.272-280, 2019 (SCI-Expanded, Scopus, TRDizin)

23. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD-AF Registry

Goto S., Angchaisuksiri P., Bassand J., Camm A. J., Dominguez H., Illingworth L., et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION , cilt.8, sa.3, 2019 (SCI-Expanded, Scopus)

24. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Szarek M., White H. D., Schwartz G. G., Alings M., Bhatt D. L., Bittner V. A., et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.73, sa.4, ss.387-396, 2019 (SCI-Expanded, Scopus)

25. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Results From the GARFIELD-AF Registry

Bassand J., Virdone S., Goldhaber S. Z., Camm A. J., Fitzmaurice D. A., Fox K. A. A., et al.

CIRCULATION , cilt.139, sa.6, ss.787-798, 2019 (SCI-Expanded, Scopus)

26. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF -

Koretsune Y., Etoh T., Katsuda Y., Suetsugu T., Kumeda K., Sakuma I., et al.

CIRCULATION JOURNAL , cilt.83, sa.1, ss.67-97, 2019 (SCI-Expanded, Scopus)

27. Alirocumab and cardiovascular outcomes after acute coronary syndrome

Schwartz G. G., Steg P. G., Szarek M., Bhatt D. L., Bittner V. A., Diaz R., et al.

New England Journal of Medicine , cilt.379, sa.22, ss.2097-2107, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Sawhney J. P. S., Kothiwale V. A., Bisne V., Durgaprasad R., Jadhav P., Chopda M., et al.

INDIAN HEART JOURNAL , cilt.70, sa.6, ss.828-835, 2018 (ESCI, Scopus)

29. Contrast-induced acute kidney injury/contrast-induced nephropathy may be related to additional risk factors Reply

Oktay V., Cirali I. C., SİNAN Ü. Y., Yildiz A., ERSANLI M. K.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.19, sa.2, ss.155-156, 2018 (SCI-Expanded, Scopus, TRDizin)

30. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry

Verheugt F. W. A., Gao H., Al Mahmeed W., Ambrosio G., Angchaisuksiri P., Atar D., et al.

EUROPEAN HEART JOURNAL , cilt.39, sa.6, ss.464-473, 2018 (SCI-Expanded, Scopus)

31. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)

Fox K. A. A., Accetta G., Pieper K. S., Bassand J., Camm A. J., Fitzmaurice D. A., et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES , cilt.4, sa.1, ss.27-35, 2018 (SCI-Expanded, Scopus)

32. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

Bassand J., Accetta G., Al Mahmeed W., Corbalan R., Eikelboom J., Fitzmaurice D. A., et al.

PLOS ONE , cilt.13, sa.1, 2018 (SCI-Expanded, Scopus)

33. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

Fox K. A. A., Lucas J. E., Pieper K. S., Bassand J., Camm A. J., Fitzmaurice D. A., et al.

BMJ OPEN , cilt.7, sa.12, 2017 (SCI-Expanded, Scopus)

34. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

Steinberg B. A., Gao H., Shrader P., Pieper K., Thomas L., Camm A. J., et al.

AMERICAN HEART JOURNAL , cilt.194, ss.132-140, 2017 (SCI-Expanded, Scopus)

35. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions

Oktay V., Cirali I. C., SİNAN Ü. Y., Yildiz A., ERSANLI M. K.

Anatolian Journal of Cardiology , cilt.18, sa.5, ss.334-339, 2017 (SCI-Expanded, Scopus, TRDizin)

36. Global healthcare resource use in 39,670 patients with AF: perspectives from GARFIELD-AF

Mantovani L., Cozzolino P., Ambrosio G., ERSANLI M. K., Kayani G., Panchenko E., et al.

EUROPEAN HEART JOURNAL , cilt.38, ss.973, 2017 (SCI-Expanded, Scopus)

37. Evolving quality standards for large-scale registries: the GARFIELD-AF experience

Fox K. A. A., Gersh B. J., Traore S., Camm A. J., Kayani G., Krogh A., et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES , cilt.3, sa.2, ss.114-122, 2017 (ESCI, Scopus)

38. Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

Camm A. J., Accetta G., Al Mahmeed W., Ambrosio G., Goldhaber S. Z., Haas S., et al.

BMJ OPEN , cilt.7, sa.3, 2017 (SCI-Expanded, Scopus)

39. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

Camm A. J., Accetta G., Ambrosio G., Atar D., Bassand J., Berge E., et al.

HEART , cilt.103, sa.4, ss.307-314, 2017 (SCI-Expanded, Scopus)

40. Relationship between myocardial performance index and severity of coronary artery disease in patients with non-ST -segment elevation acute coronary syndrome

Abaci O., Kocas C., Oktay V., ARSLAN Ş., Turkmen Y., Bostan C., et al.

Cardiovascular Journal of Africa , cilt.28, sa.1, ss.4-7, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Validation of SYNTAX and clinical SYNTAX scores in predicting atrial fibrillation following on-pump coronary artery bypass grafting

Oktay V., Cirali I. C., SİNAN Ü. Y., Yildiz A., ERSANLI M. K., Ozsoy D., et al.

Turkish Journal of Thoracic and Cardiovascular Surgery , cilt.25, sa.3, ss.333-339, 2017 (SCI-Expanded, Scopus, TRDizin)

42. 33 Questions about Triglycerides and Cardiovascular Effects: Expert Answers

ÇETİNKALP Ş., Koylan N., ÖZER N., Onat A., ÖZGEN A. G., Koldas Z. L., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.45, ss.1-63, 2017 (ESCI, Scopus, TRDizin)

43. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

Oh S., Goto S., Accetta G., Angchaisuksiri P., Camm A. J., Cools F., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.223, ss.543-547, 2016 (SCI-Expanded, Scopus)

44. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

Haas S., ten Cate H., Accetta G., Angchaisuksiri P., Bassand J., Camm A. J., et al.

PLOS ONE , cilt.11, sa.10, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

Bassand J., Accetta G., Camm A. J., Cools F., Fitzmaurice D. A., Fox K. A. A., et al.

EUROPEAN HEART JOURNAL , cilt.37, sa.38, ss.2882-2890, 2016 (SCI-Expanded, Scopus)

46. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

Fitzmaurice D. A., Accetta G., Haas S., Kayani G., Lucas Luciardi H., Misselwitz F., et al.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.174, sa.4, ss.610-623, 2016 (SCI-Expanded, Scopus)

47. Comparison of Long-Term Outcomes in Real-World Patients Between Resolute Zotarilumus-Eluting and Paclitaxel-Eluting Stents in Small Vessel

KILICKESMEZ K., KOCAŞ B., YILDIZ A., COSKUN U., Ersanli M. K., ARAT A., et al.

ANGIOLOGY , cilt.67, sa.5, ss.490-495, 2016 (SCI-Expanded, Scopus)

48. Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation

Kocas C., Abaci O., Kocas B. B., Cetinkal G., ARSLAN Ş., Yildiz A., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.203, ss.529-531, 2016 (SCI-Expanded, Scopus)

49. Contrast-induced acute kidney injury in patients with non-ST-segment elevation myocardial infarction undergoing early versus delayed invasive strategy

KOCAS B., ABACI O., CETINKAL G., ARSLAN Ş., Dalgic Y., KOCAS C., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.203, ss.638-639, 2016 (SCI-Expanded, Scopus)

50. The role of media on statin adherence

Kocas C., Abaci O., Kocas B. B., Cetinkal G., Arslan Ş., Yildiz A., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.201, ss.139, 2015 (SCI-Expanded, Scopus)

51. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

KOCAS C., YILDIZ A., ABACI O., KARACA O., FIRDIN N., Dalgic Y., et al.

ANGIOLOGY , cilt.66, sa.10, ss.964-968, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Long-Term Follow-Up of Patients at High Risk for Nephropathy After Contrast Exposure

Abaci O., Harmankaya O., Kocas B., Kocas C., Bostan C., Coskun U., et al.

ANGIOLOGY , cilt.66, sa.6, ss.514-518, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Bonaca M. P., Bhatt D. L., Cohen M., Steg P. G., Storey R. F., Jensen E. C., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.372, sa.19, ss.1791-1800, 2015 (SCI-Expanded, Scopus)

54. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

Lip G. Y. H., Rushton-Smith S. K., Goldhaber S. Z., Fitzmaurice D. A., Mantovani L. G., Goto S., et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES , cilt.8, sa.2, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Admission Hyperglycemia Is Associated with Failed Reperfusion Following Fibrinolytic Therapy in Patients with STEMI: Results of a Retrospective Study

Kocas C., Abaci O., Halil G. S., ARSLAN Ş., Cetinkal G., Bostan C., et al.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS , cilt.15, sa.1, ss.35-42, 2015 (SCI-Expanded, Scopus)

56. Relationship between serum endothelin-1 level and spontaneous reperfusion in patients with acute myocardial infarction.

KILICKESMEZ K., BINGÖL G., BULUT L., Sinan U., ABACI O., ERSANLI M. K., et al.

Coronary artery disease , cilt.26, ss.37-41, 2015 (SCI-Expanded, Scopus)

57. The importance of apoptotic activity and plasma NT-proBNP levels in patients with acute exacerbation of decompensated heart failure and their relation to different drugs and comorbidities

Sarimehmetoglu A. C., Gultekin N., Kucukates E., YILDIZ A., Kocas C., ERSANLI M. K.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION , cilt.64, sa.8, ss.884-891, 2014 (SCI-Expanded, Scopus)

58. Percutaneous coronary intervention vs. optimal medical therapy - The other side of the coin: Medication adherence

Kocas C., Abaci O., Oktay V., Coşkun U. C., Bostan C., Yıldız A., et al.

Journal of Clinical Pharmacy and Therapeutics , cilt.38, sa.6, ss.476-479, 2013 (SCI-Expanded, Scopus)

59. Cardiac Tamponade due to Left Ventricular Pseudoaneurysm After Aortic Valve Replacement

Baydar O., Coskun U., Balaban B., Cetin G., Firatli I., ERSANLI M. K., et al.

HEART SURGERY FORUM , cilt.16, sa.1, 2013 (SCI-Expanded, Scopus)

60. Admission Hyperglycemia and TIMI Frame Count in Primary Percutaneous Coronary Intervention

Yildiz A., Arat-Ozkan A., Kocas C., Abaci O., Coskun U., Bostan C., et al.

ANGIOLOGY , cilt.63, sa.5, ss.325-329, 2012 (SCI-Expanded, Scopus)

61. The Relationship Between Chronic Kidney Disease and SYNTAX Score

Coskun U., Kilickesmez K. O., Abaci O., Kocas C., Bostan C., Yildiz A., et al.

ANGIOLOGY , cilt.62, sa.6, ss.504-508, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Congenital absence of the left circumflex coronary artery and an unusually dominant course of the right coronary artery

Baskurt M., Okcun B., Caglar I. M., Özkan A., Ersanli M. K., Gurmen T.

CARDIOVASCULAR JOURNAL OF AFRICA , cilt.21, sa.5, ss.286-288, 2010 (SCI-Expanded, Scopus)

63. Chronic Kidney Disease as a Predictor of Coronary Lesion Morphology

Kilickesmez K. O., Abaci O., Okcun B., Kocas C., Baskurt M., Arat A., et al.

ANGIOLOGY , cilt.61, sa.4, ss.344-349, 2010 (SCI-Expanded, Scopus)

64. THE EFFECT OF ELECTROCARDIOGRAPHIC ISCHEMIA GRADE ON REPERFUSION IN ST-ELEVATION MYOCARDIAL INFARCTION

Baskurt M., Gulsen K., Ayca B., Okcun B., Ozkan A. A., ERSANLI M. K., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.140, 2010 (SCI-Expanded, Scopus)

65. P WAVE DISPERSION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND TO DETERMINE ITS RELATIONSHIP WITH THE SEVERITY OF THE DISEASE

Akin F., Firatli I., Gurmen T., ERSANLI M. K., Kucukoglu S., Yigit Z.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.140, 2010 (SCI-Expanded, Scopus)

66. N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy

Baskurt M., Okcun B., Abaci O., Dogan G. M., Kilickesmez K., Özkan A., et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , cilt.39, sa.9, ss.793-799, 2009 (SCI-Expanded, Scopus)

67. N-acetylcsteine versus N-acetylcsteine plus teophyllin for the prevention of contrast induced nephropathy

Baskurt M., Abaci O., Okcun B., Dogan G. M., Kilickesmez K., Uzunhasan I., et al.

EUROPEAN HEART JOURNAL , cilt.29, ss.848, 2008 (SCI-Expanded, Scopus)

68. THE AFFECT OF DIABETES MELLITUS TO ISCHEMIA GRADE AND ACHIVEMENT OF THE THROMBOLYTHIC THERAPHY IN ST ELEVATION MYOCARDIAL INFARCTION

Gulsen K., Okcun B., Baskurt M., Uzunhasan I., Arat A., Gurmen T., et al.

ATHEROSCLEROSIS SUPPLEMENTS , cilt.9, sa.1, ss.267, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Serum PON-1 activity and TBARS levels correlate with angiographic extent and severity of coronary artery disease

Arat-Ozkan A., Gurmen T., Kaya A., Yiğit Z., Ersanli M. K., Kucukoglu S.

EUROPEAN HEART JOURNAL , cilt.28, ss.107, 2007 (SCI-Expanded, Scopus)

70. What is the primary treatment in atrial fibrillation: rate or rhythm control with long term anticoagulation?

Okcun B. A. R. I. S., Yigit Z. E. R. R. I. N., Arat A. L. E. V., Baskurt M. U. R. A. T., Gurmen T. E. V. F. I. K., ERSANLI M. K., et al.

EUROPEAN HEART JOURNAL , cilt.28, ss.806-807, 2007 (SCI-Expanded, Scopus)

71. A patient with bicuspid aorta and intercoronary continuity - A rare variant of coronary circulation

Arat-Ozkan A., GURMEN T., ERSANLI M. K., OKCUN B., BABALIK E. E., KUCUKOGLU M. S.

JAPANESE HEART JOURNAL , cilt.45, sa.1, ss.153-155, 2004 (SCI-Expanded, Scopus)

72. The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation

Yigit Z., AKDUR H., Ersanli M. K., Okcun B., GUVEN O.

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY , cilt.8, sa.4, ss.308-312, 2003 (SCI-Expanded, Scopus)

73. Revascularization of chronic coronary artery occlusions using laser debulking followed by stent implantation

Babalik E., Gurmen T., Gulbaran M., ERSANLI M. K., Ozturk S.

ACTA CARDIOLOGICA , cilt.58, sa.2, ss.149-153, 2003 (SCI-Expanded, Scopus)

74. Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients

Babalik E., Gurmen T., Orhan L., Bulur H., Gulbaran M., ERSANLI M. K., et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS , cilt.58, sa.3, ss.306-312, 2003 (SCI-Expanded, Scopus)

75. The role of gender on early and late prognosis of percutaneous mitral balloon valvulotomy in rheumatic mitral stenosis.

Yazicioglu N., Enar R., Pehlivanoglu S., ERSANLI M. K.

CIRCULATION , cilt.94, sa.8, ss.2156, 1996 (SCI-Expanded, Scopus)

76. THE PATHOGENIC ROLE OF DIABETES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO RECEIVED THROMBOLYTIC THERAPY

ERSANLI M. K., ENAR R., ERSANLI Z., PAHLIVANOGLU S., YAZICIOGLU N.

DIABETOLOGIA , cilt.38, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. “Unstable Anginada C-reaktif protein yükselmesinin anlamı.”

GURMEN T., PEHLIVANOĞLU S., ERSANLI M. K., ÖZTÜRK S., KOCAZEYBEK B. S., DEMİRCİOĞLU C.

TÜRK GÖĞÜS KALP DAMAR CERRAHİSİ DERGİSİ , sa.1, ss.98-101, 1992 (SCI-Expanded, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. The association of statin adherence and in-stent restenosis

Kocas C., Abaci O., Kocas B. B., Cetinkal G., ARSLAN Ş., YILDIZ A., et al.

Congress of the European-Society-of-Cardiology (ESC), London, Kanada, 29 Ağustos - 02 Eylül 2015, cilt.36, ss.472, (Özet Bildiri)

2. Contrast-induced acute kidney injury in patients with non ST-segment elevation myocardial infarction undergoing early versus delayed invasive strategy

Kocas B., Abaci O., Cetinkal G., ARSLAN Ş., Dalgic Y., Kocas C., et al.

Congress of the European-Society-of-Cardiology (ESC), London, Kanada, 29 Ağustos - 02 Eylül 2015, cilt.36, ss.72-73, (Özet Bildiri)

3. The Coronary Care Unit Profile and Outcomes: What Has Changed in the Last Decade?

Calpar I., Karaca O. S., Buyuk A., Bostan C., Yildiz A., Ersanli M. K., et al.

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri)

4. PCI vs Optimal Medical Therapy - The Other Side of the Coin: Medication Adherence

Kocas C., Abaci O., Oktay V., Coskun U., Bostan C., Yildiz A., et al.

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri)

5. Pentraxin-3 a novel biomarker for predicting coronary artery disease

YIGIT S., SARI S., Canbolat I. P., Özkan A., Ersanli M. K., Gurmen T.

Congress of the European-Society-of-Cardiology (ESC), Amsterdam, Hollanda, 31 Ağustos - 04 Eylül 2013, cilt.34, ss.566, (Özet Bildiri)

6. PCI vs Optimal medical therapy - the other side of the coin: medication adherence

Kocas C., Abaci O., Oktay V., Bostan C., Coskun U., ÖZKAN A., et al.

Congress of the European-Society-of-Cardiology (ESC), Amsterdam, Hollanda, 31 Ağustos - 04 Eylül 2013, cilt.34, ss.1002, (Özet Bildiri)

7. Neopterin leves in coronary artery disease subsets

Abaci O., Kocas C., Özkan A., Kaya A., Kilickesmez K., Okcun B., et al.

13th Annual Meeting of the European-Council-for-Cardiovascular-Research, Nice, Fransa, 10 - 12 Ekim 2008, cilt.52, ss.760-761, (Özet Bildiri)

8. Risk profile and lipid peroxidation in young patients with coronary artery disease

Kocas C., Abaci O., Özkan A., Kaya A., Okcun B., Kilickesmez K., et al.

13th Annual Meeting of the European-Council-for-Cardiovascular-Research, Nice, Fransa, 10 - 12 Ekim 2008, cilt.52, ss.762, (Özet Bildiri)

9. The effect of plasma homocysteine levels on clinical reperfusion after thrombolytic therapy

Okuyan E., ERSANLI M. K., Mutlu H., Gultekin N.

75th Congress of the European-Atherosclerosis-Society, Prague, Çek Cumhuriyeti, 23 - 26 Nisan 2005, cilt.6, ss.144, (Özet Bildiri)

10. QT dispersion in Arg 403 Gin missence point mutation of beta-myosin-heavy-chain in hypertrophic cardiomyopathy families

ERSANLI M. K., Gultekin N., Kucukates E., Mutlu H.

Congress of the European-Society-of-Cardiology, Berlin, Almanya, 31 Ağustos - 04 Eylül 2002, cilt.23, ss.44, (Özet Bildiri)

11. Value of right derivation records in treadmill test taken simultaneously with standard left derivations in the diagnosis ischaemia

Yigit Z., Atinc N., Binici G., ERSANLI M. K., Akdur H., Yuksel H., et al.

Congress of the European-Society-of-Cardiology, Berlin, Almanya, 31 Ağustos - 04 Eylül 2002, cilt.23, ss.583, (Özet Bildiri)

12. The effect of exercise to P-wave dispersion and its evaluation as a predictor of atrial fibrillation

Yigit Z., ERSANLI M. K., Akdur H., Okcun B., Guzelsoy D., Guven O.

Congress of the European-Society-of-Cardiology, Berlin, Almanya, 31 Ağustos - 04 Eylül 2002, cilt.23, ss.660, (Özet Bildiri)

13. The 403Arg?Gin missense point mutation of b-myosin-heavy-chain in hypettrophic cardiomyopathy families in a diverse Turkish population and its relation with sudden cardiac death

KÜÇÜKATEŞ E., ERSANLI M. K., GÜLTEKİN N. N., Sayhan N., Kalfoğlu E., MUTLU H., et al.

XIXth Congress of the European Society of Cardiology, Stockholm, İsveç, 24 - 28 Ağustos 1997, cilt.18, ss.229, (Özet Bildiri)

14. THE INCIDENCE OF SUBCLAVIAN THROMBOSIS FOLLOWING PERMANENT PACEMAKER IMPLANTATION

CELIKER C., SAYMAN H. B., ERSANLI M. K., HAMIDI M., DOGRUCA Z., ONSEL C., et al.

7th European Symposium on Cardiac Pacing (EUROPACE 95), İstanbul, Türkiye, 4 - 07 Haziran 1995, ss.437-440, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

8096

H-İndeks (WoS)

Atıf (Scopus)

8785

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler